[ Visit Client Website ]

Before you can access ASH's online program, you must agree to the following:
  • Abstracts submitted to the ASH Annual Meeting are considered embargoed from the time of submission.
  • The media, companies and institutions issuing press releases, and others are required to abide by the embargo policies governing the Society’s annual meeting. Read ASH’s embargo policy for more information.
Last updated December 3, 2009. Please note that this site represents the latest program changes
and differs from the print version in some details.

51st ASH Annual Meeting and Exposition (December 5-8, 2009)

Saturday, December 5, 2009

7:00 AM-5:00 PM

7:30 AM-9:00 AM

9:00 AM-9:30 AM

9:00 AM-7:30 PM

9:30 AM-11:00 AM

11:00 AM-12:30 PM

11:15 AM-12:15 PM

Acute and Chronic Idiopathic Thrombocytopenic Purpura
James B. Bussel, MD Weill Cornell Medical College, New York, NY

Advances in Cord Blood Transplantation
Eliane Gluckman Eurocord/Saint-Louis Hospital, Paris France

Chronic Lymphocytic Leukemia
Kanti R. Rai, MD North Shore Long Island Jewish Health System, New Hyde Park, NY

Cord Blood Stem Cell Expansion
Elizabeth J. Shpall, MD The University of Texas, M.D. Anderson Cancer Center, Houston, TX

Erythrocyte Disorders in the Perinatal Period
Patrick G. Gallagher, MD Yale University School of Medicine, New Haven, CT

Importance of Cytogenetics in Chronic Lymphocytic Leukemia
Stephan Stilgenbauer, MD University of Ulm, Ulm Germany

Iron Overload Diagnosis and Treatment
Alan Richard Cohen, MD Children's Hospital of Philadelphia, Philadelphia, PA

Management of Myelodysplastic Syndromes
Alan F. List, MD H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL

Managing Early Stage Hodgkin Lymphoma
Ralph M. Meyer, MD National Cancer Institute of Canada Clinical Trials Group, Queen's University, Kingston Canada

Measuring Response to Chronic Myelogenous Leukemia Therapy
Susan Branford, PhD SA Pathology, Adelaide Australia

Molecular Genetics of Acute Myeloid Leukemia
Bob Löwenberg Erasmus University Medical Center, Rotterdam Netherlands

Monoclonal Gammopathies
Geraldine P. Schechter, MD Washington VA Medical Center & George Washington University, Washington, DC

Multiple Myeloma
S. Vincent Rajkumar, MD Mayo Clinic College of Medicine, Rochester, MN

Peripheral T-Cell Lymphoma
Ginna G. Laport, MD Stanford University, Stanford, CA

Prognostic Factors in Acute Myeloid Leukemia
Clara D. Bloomfield, MD The Ohio State University, James Cancer Hospital, Columbus, OH

Regulatory T-Cells
Robert Negrin, MD Stanford University, Stanford, CA

Relapsed Follicular Lymphoma
Jonathan W. Friedberg, MD, MMSc University of Rochester, Rochester, NY

Telomeres in 2009
Peter M. Lansdorp, MD, PhD Terry Fox Laboratory, Vancouver, British Columbia

Andrew I. Schafer, MD Weill Cornell Medical College, New York, NY

Thrombophilias: Clinically Relevant Aspects
Stephan Moll, MD University of North Carolina, Chapel Hill, NC

Transfusions in Sickle Cell Disease
Kim Smith-Whitley, MD Children's Hospital of Philadelphia, Philadelphia, PA

12:30 PM-1:30 PM

1:30 PM-2:00 PM

1:30 PM-4:00 PM

2:00 PM-3:30 PM

4:00 PM-5:30 PM

5:30 PM-7:30 PM

6:00 PM-7:30 PM

6:30 PM-9:00 PM

7:30 PM-8:30 PM